2023 ARCHIVES
Creating First in Class Multispecific Antibody Modalities
The bispecific antibodies stream at the PEGS Summit will take you through a review of constructs, to the engineering and platform development all the way to preclinical and clinical data. Newer platforms, innovative approaches and constructs are combining to yield unprecedented efficacy. Don’t miss the most significant forum of the year to hear about new advances in the industry and meet face to face with leaders changing the future of biologics.
Conferences and Training Seminars Include:
May 15-16
Introduction to Bispecific Antibodies
May 16-17
Advancing Bispecific Antibodies and Combination Therapy to the Clinic
May 18-19
Engineering Bispecific Antibodies
Keynote Presentations:
Triggered BispecificsJoAnn A. Suzich, PhD, Head, Research, Immunocore LLC
Antibody-Cytokine Fusions for the Treatment of Difficult-to-Cure Cancer Types: Emerging Clinical ResultsDario Neri, PhD, CEO and CSO, Philogen
View By:
May 12-13
Display of Biologics
Antibodies for Cancer Therapy
Advances in Immunotherapy
Difficult-to-Express Proteins
ML and Digital Integration in Biotherapeutic Analytics
Biologics for Immunology Indications
May 13-14
Engineering Antibodies
Advancing Multispecific Antibodies
Emerging Targets for Oncology and Beyond
Engineering Cell Therapies
Optimizing Protein Expression
Biophysical Methods
Predicting Immunogenicity with AI/ML Tools
Radiopharmaceutical Therapies
Machine Learning for Protein Engineering
Driving Clinical Success in Antibody-Drug Conjugates
Engineering Bispecific and Multifunctional Antibodies
Next-Generation Immunotherapies
Maximizing Protein Production Workflows
Characterization for Novel Biotherapeutics